Ping An Biomedical Co., Ltd. (PASW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 09-30. Amounts in USD.

Revenue Annual

0 2M 4M 6M FY25: 4.8M FY25

Gross Profit Annual

0 50K 100K 150K FY25: 133.4K FY25

Operating Income Annual

-2.4M -1.6M -800K 0 800K 1.6M 2.4M FY25: -2.1M FY25

Net Income Annual

-2.1M -1.4M -700K 0 700K 1.4M 2.1M FY25: -1.8M FY25

Cost of Revenue Annual

0 2M 4M 6M FY25: 4.7M FY25

Operating Cash Flow Annual

-1.1M -700K -350K 0 350K 700K 1.1M FY25: -902.9K FY25

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 7M 14M 21M FY23: 18M FY24: 18M FY25: 18.5M FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.